Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2017-A00131-52 | Other Identifier | ID-RCB number, ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to validate a french version of the 5 minutes version of the Montreal Cognitive Assessment as compared to the french full version of this test.
The Montreal Cognitive Assessment (MOCA) is a test used to detect cognitive impairments. This test is available in different languages including french. A short version (the 5 minutes MOCA) has also been validated through a phone call use that allows to develop some epidemiological approaches. Nevertheless, this short version has not been validated in french.
The main aim of the study is to validate the french translation of the short version of the MOCA as compared the the full french version of the test.
To validate the short version, several groups of subjects will be included : healthy subjects, Alzheimer disease patients, Parkinson or Huntington diseases patients as well as diabetic patients.
The inclusion of both healthy subjects and patients with different types of cognitive impairments will allow to validate the short version of the test.
All subjects and patients will first be submitted to the full version of the MOCA during a face to face procedure. Thirty to forty days later, they will be submitted to the short version of the test through a phone call performed by an independent rater.
Subgroups of healthy subjects and patients will also be used to determine the test-retest and inter-rater reliability of the short version of the MOCA.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy subjects | Other | Subjects will be submitted to both the full version of the Montreal Cognitive Assessment and of the 5-minutes version of the Montreal Cognitive Assessment |
|
| Alzheimer patients | Other | Patients will be submitted to both the full version of the Montreal Cognitive Assessment and of the 5-minutes version of the Montreal Cognitive Assessment |
|
| Parkinson and Huntington patients | Other | Patients will be submitted to both the full version of the Montreal Cognitive Assessment and of the 5-minutes version of the Montreal Cognitive Assessment |
|
| Diabetic patients | Other | Patients will be submitted to both the full version of the Montreal Cognitive Assessment and of the 5-minutes version of the Montreal Cognitive Assessment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Full version of the Montreal Cognitive Assessment | Diagnostic Test | Patients or subjects will be submitted to the full version of the MOCA |
|
| Measure | Description | Time Frame |
|---|---|---|
| Correlation between scores obtained with the different versions of the MOCA | To measure the correlation between the results obtained at the short and full versions of the MOCA | 30 to 40 days |
| Measure | Description | Time Frame |
|---|---|---|
| Performance of the short version of the MOCA | Receiver operator characteristic (ROC) analyses of the short version of MOCA to determine cognitive impairment as compared to full version as a gold-standard | 30 to 40 days |
| Test-retest reliability |
Not provided
Inclusion Criteria:
Healthy Volunteers
Patients
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dominique Deplanque, MD,PhD | University Hospital, Lille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital | Lille | 59037 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019954 | Neurobehavioral Manifestations |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Different populations including subjects with or without cognitive impairment will be used to determine the accuracy of a short version of the MOCA as compared to the full version of this scale.
Not provided
Not provided
Not provided
Not provided
| 5 minutes version of the Montreal Cognitive Assessment | Diagnostic Test | The same patients and subjects will be submitted to the 5 minutes version of the MOCA through a phone call |
|
To determine the test-retest reliability of the short version of the MOCA
| 30 to 40 days |
| Inter-rater reliability | To determine the inter-rater reliability of the short version of the MOCA | 30 to 40 days |